BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 26 filers reported holding BENITEC BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $479,000 | – | 1,289,128 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 796,837 | $296,000 | 1.76% |
| Altium Capital Management LP | 658,796 | $245,000 | 0.09% |
| CVI Holdings, LLC | 1,289,128 | $479,000 | 0.04% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $286,000 | 0.01% |
| ARMISTICE CAPITAL, LLC | 1,555,039 | $578,000 | 0.01% |
| FRANKLIN RESOURCES INC | 10,000,000 | $3,717,000 | 0.00% |
| WealthTrust Axiom LLC | 12,950 | $4,000 | 0.00% |
| CANTOR FITZGERALD, L. P. | 133,805 | $50,000 | 0.00% |
| Walleye Capital LLC | 190,678 | $71,000 | 0.00% |
| UBS Group AG | 28,683 | $11,000 | 0.00% |